Compare FMC Corp (FMC) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Tempus AI — how do they compare? FMC Corp trades at $8.53 (market cap $1.39B), while Tempus AI trades at $71.1 (market cap $12.58B). The key difference: Tempus AI is far larger — about 9.1× FMC Corp's market cap, and FMC Corp pays a 3.59% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold FMC Corp for 68 Days and Tempus AI for 22 Days on average.
| FMC | TEM | |
|---|---|---|
Market Cap | $1.39B | $12.58B |
Volume | 4,145,979 | 7,444,569 |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $30.63 | $99.28 |
52-Week Low | $8.44 | $41.55 |
Typical Hold Time | 68 Days | 22 Days |
Enterprise Value | $5.19B | $13.21B |
Dividend Yield | 3.59% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (NYSE: FMC) trades at $8.695, down 4.35% today, reflecting ongoing challenges in the agricultural chemicals sector. The stock shows bearish technical signals with mixed earnings performance - beating Q1 and Q2 2026 estimates but missing Q4 2025. Fundamentally, the company faces significant headwinds with a net income margin of -84.83% and negative ROE of -91.47%, though valuation metrics like P/S of 0.34 and P/B of 0.85 suggest potential undervaluation. Recent developments include regulatory submissions for new herbicides in Brazil and a minority equity investment from Tessenderlo Group.
The investment outlook remains cautious despite analyst consensus pointing to 68% upside potential with a $14.60 price target. While aggressive deleveraging efforts and new product pipelines offer potential catalysts, substantial earnings losses, volatile cash flows, and high debt levels present significant risks. The agricultural sector's cyclical nature and pricing pressures require careful monitoring of the company's turnaround execution and market conditions.
Tempus AI (TEM) trades at $72.15, up 2.65% today, with a bullish technical signal and strong analyst support. The stock shows recent earnings beats but remains unprofitable, with a net income margin of -17.77% for 2026. Positive developments include FDA clearance for an AI product and expanded data partnerships, fueling investor optimism in the healthtech sector.
Outlook is cautiously optimistic given growth potential in AI-driven diagnostics, but high valuation (P/S 8.61) and persistent losses pose risks. Upside hinges on revenue scaling and path to profitability, with a consensus price target of $72.60 suggesting limited near-term gains from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
